Utah Medical Products, Inc. (NASDAQ:UTMD – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 58,600 shares, an increase of 158.1% from the January 15th total of 22,700 shares. Based on an average trading volume of 12,700 shares, the days-to-cover ratio is presently 4.6 days. Currently, 1.7% of the shares of the company are short sold.
Analyst Upgrades and Downgrades
Separately, StockNews.com upgraded shares of Utah Medical Products from a “buy” rating to a “strong-buy” rating in a research note on Friday.
Utah Medical Products Trading Up 2.2 %
Utah Medical Products (NASDAQ:UTMD – Get Free Report) last posted its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $1.18 earnings per share for the quarter. The company had revenue of $12.33 million for the quarter. Utah Medical Products had a net margin of 33.12% and a return on equity of 13.73%.
Utah Medical Products Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 3rd. Shareholders of record on Friday, March 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend is Thursday, March 14th. Utah Medical Products’s dividend payout ratio is currently 26.26%.
Hedge Funds Weigh In On Utah Medical Products
A number of large investors have recently bought and sold shares of the stock. Isthmus Partners LLC raised its stake in Utah Medical Products by 6.5% during the fourth quarter. Isthmus Partners LLC now owns 22,699 shares of the medical instruments supplier’s stock worth $1,912,000 after purchasing an additional 1,392 shares during the period. Advisory Services Network LLC raised its stake in shares of Utah Medical Products by 47.8% in the 4th quarter. Advisory Services Network LLC now owns 4,885 shares of the medical instruments supplier’s stock valued at $411,000 after acquiring an additional 1,579 shares during the period. Brandes Investment Partners LP raised its stake in shares of Utah Medical Products by 21.2% in the 4th quarter. Brandes Investment Partners LP now owns 32,825 shares of the medical instruments supplier’s stock valued at $2,765,000 after acquiring an additional 5,746 shares during the period. UBS Group AG raised its stake in shares of Utah Medical Products by 76.7% in the 4th quarter. UBS Group AG now owns 4,858 shares of the medical instruments supplier’s stock valued at $409,000 after acquiring an additional 2,108 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of Utah Medical Products by 2.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 163,044 shares of the medical instruments supplier’s stock valued at $13,732,000 after acquiring an additional 3,128 shares during the period. Hedge funds and other institutional investors own 70.35% of the company’s stock.
About Utah Medical Products
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
- Five stocks we like better than Utah Medical Products
- What is a SEC Filing?
- 3 attractive stocks that insiders are buying
- Golden Cross Stocks: Pattern, Examples and Charts
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- ESG Stocks, What Investors Should Know
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.